JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Up 15.8% in June

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) saw a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 517,600 shares, a growth of 15.8% from the June 15th total of 447,000 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

JCR Pharmaceuticals Price Performance

JCRRF stock remained flat at $5.22 during mid-day trading on Monday. JCR Pharmaceuticals has a 1 year low of $5.22 and a 1 year high of $6.20. The company’s fifty day moving average is $5.22 and its 200-day moving average is $6.42.

About JCR Pharmaceuticals

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.